CDL Inquiry helps commercial drivers, owner-operators, small fleets, and employers coordinate Minnesota DOT drug testing without unnecessary delays or confusion. Schedule the correct DOT drug or alcohol test, locate an appropriate collection site, manage random testing requirements, or enroll a covered driver in our affordable $110 annual DOT consortium program.
Minnesota DOT drug testing applies to covered commercial drivers and employers subject to Federal Motor Carrier Safety Administration drug and alcohol testing requirements. These federal obligations can apply whether a driver operates primarily within Minnesota or travels across state lines.
A DOT drug or alcohol test is not the same as an ordinary workplace screening. The test must be registered under the correct federal authority, ordered for the appropriate testing reason, completed using the required procedures, and documented properly. A driver may visit a collection facility and complete a test that does not satisfy the employer’s FMCSA obligation if the order was incorrectly entered as a non-DOT test or registered under the wrong testing reason.
CDL Inquiry helps drivers and companies throughout Minnesota, including Minneapolis, Saint Paul, Rochester, Duluth, Bloomington, Brooklyn Park, Plymouth, St. Cloud, Woodbury, Eagan, Maple Grove, Eden Prairie, Coon Rapids, Burnsville, Blaine, Lakeville, Minnetonka, Apple Valley, Edina, St. Louis Park, Mankato, Moorhead, Shakopee, Maplewood, Cottage Grove, Richfield, Roseville, Inver Grove Heights, Andover, Savage, and surrounding Minnesota communities.
Collection-site availability can differ significantly by location. Some facilities perform DOT drug collections but do not provide DOT alcohol testing. Others may require an appointment, limit their collection hours, or stop accepting drivers before the facility’s posted closing time. Return-to-duty and follow-up testing may also require a location that can accommodate the necessary collection procedures.
CDL Inquiry coordinates pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up testing. We also administer an affordable annual consortium program for Minnesota owner-operators, one-driver businesses, and qualifying employers that need support managing random drug and alcohol testing participation.
A nearby clinic may provide several workplace testing services, but that does not guarantee it can complete the precise FMCSA-regulated service required. Contact CDL Inquiry first so the testing reason, registration information, collection-site capability, and driver instructions can be confirmed before the driver travels.
Our goal is to make Minnesota DOT drug testing easier to coordinate while helping drivers and employers avoid preventable registration, scheduling, and collection-site problems.
CDL Inquiry helps locate a suitable testing facility based on the driver’s current location, travel route, and required testing service. This is useful when a driver is away from the employer’s main office or needs testing in another Minnesota community.
The nearest facility is not always the correct facility. We help confirm important location details before directing the driver to the testing center.
Pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up tests serve different compliance purposes. The reason entered on the testing order should match the employer’s actual FMCSA testing need.
Correct registration helps reduce the risk of completing an ordinary workplace test when a federally regulated DOT test was required.
Drivers and employers can contact CDL Inquiry for help with the next scheduling step. We help coordinate the order, identify an appropriate facility, and provide basic instructions for completing the collection.
This support can save time for owner-operators, safety managers, dispatchers, human resources teams, fleet administrators, and drivers operating under demanding schedules.
CDL Inquiry offers DOT consortium enrollment for $110 per driver per year. This flat-rate program gives Minnesota owner-operators, small fleets, and covered employers an affordable way to manage the required pre-employment drug test and random drug and alcohol testing participation.
The annual enrollment price is designed to be clear and predictable. The required pre-employment drug test is included, and enrolled drivers selected for random drug or random alcohol testing do not pay a separate testing fee for those included random tests during the enrollment year. Post-accident, reasonable suspicion, return-to-duty, and follow-up testing are separate services.
A consortium or third-party administrator can assist with random selections, testing notifications, collection-site coordination, and other agreed program functions. However, the motor carrier or employer remains responsible for maintaining compliance. The employer must keep its covered-driver roster current, respond to testing selections, direct drivers to test promptly, preserve required records, and prevent prohibited drivers from performing safety-sensitive functions.
Consortium participation is particularly important for covered owner-operators and one-driver businesses. An owner-operator may be both the company owner and its only driver, but the business still needs an independently administered random testing process. Enrollment should be completed before covered operations begin, and the owner-operator must remain available for testing selections throughout the enrollment period.
The correct testing service depends on why the test is required. Federal testing reasons are not interchangeable, and each category can involve different timing, documentation, employer decisions, and collection requirements.
| Testing Service | When It Is Used | CDL Inquiry Support | Price or Program |
|---|---|---|---|
| Pre-Employment Drug Testing | Before a covered driver first performs a safety-sensitive function for an employer, subject to the applicable FMCSA requirements and any properly documented regulatory exception. | Test registration, collection-site coordination, and driver scheduling instructions. | Included with the $110 annual consortium enrollment. |
| Random Drug and Alcohol Testing | When a covered driver is selected through a compliant random testing process administered by an employer or consortium. | Consortium administration, selection support, registration, and collection-site coordination. | All selected random drug and alcohol tests are included during the enrollment year. |
| Post-Accident Testing | Following an accident that meets the applicable FMCSA post-accident testing criteria. | Time-sensitive registration and help locating an available collection facility when testing is required. | $65 drug test and $65 alcohol test. |
| Reasonable Suspicion Testing | When a properly trained supervisor makes specific, contemporaneous, and articulable observations that support testing under the applicable requirements. | Discreet test registration and collection-site scheduling assistance. | View reasonable suspicion testing . |
| Return-to-Duty Testing | After the driver completes the required substance abuse professional process and becomes eligible for a properly ordered return-to-duty test. | Direct-observation test registration and collection-site coordination. | $95 per direct-observation test. |
| Follow-Up Testing | According to the testing plan established after the driver completes the applicable return-to-duty process. | Scheduling and direct-observation coordination for each required follow-up test. | $95 per direct-observation test . |
Not every commercial vehicle accident automatically requires FMCSA post-accident drug and alcohol testing. The employer must evaluate the available facts against the applicable federal criteria. When testing is required, coordination should begin promptly because testing attempts and documentation obligations can be time-sensitive.
FMCSA drug and alcohol testing requirements generally apply to employers and drivers who operate commercial motor vehicles requiring a commercial driver’s license. Coverage depends on the driver’s safety-sensitive duties, the vehicle, the operation, and the applicable federal regulations—not merely the company’s size or whether the driver regularly crosses the Minnesota state line.
A covered owner-operator can be both the employer and the driver. That structure does not remove DOT testing obligations. Owner-operators operating a commercial motor vehicle that requires a CDL generally need consortium participation so random testing is administered independently.
A company with only one or two covered CDL drivers can have the same core testing responsibilities as a much larger motor carrier. Small fleets often benefit from consortium administration because they may not have a dedicated safety or compliance department.
Larger employers may use CDL Inquiry to support existing internal compliance operations, schedule tests for drivers away from their terminal, or locate appropriate facilities throughout Minnesota and across the nationwide collection-site network.
A newly hired covered driver generally must have the appropriate verified negative pre-employment drug test result before first performing a safety-sensitive function, unless a specific regulatory exception applies and is documented correctly.
A driver selected through the employer’s or consortium’s random process must proceed as instructed after notification. Employers should avoid giving advance notice that could undermine the unannounced nature of random testing.
A driver with an unresolved DOT drug or alcohol program violation cannot simply complete an ordinary test and resume driving. The applicable substance abuse professional and return-to-duty process must be completed before covered safety-sensitive work is permitted.
Do not assume that a nearby urgent-care center, laboratory, medical clinic, or occupational health facility can complete the exact DOT service required without advance registration.
Testing facilities have different operating hours, appointment policies, staffing, and service capabilities. A location that performs DOT drug collections may not provide DOT alcohol testing. A facility may also have limited direct-observation availability or stop accepting collections before the building closes.
CDL Inquiry can help confirm the testing reason, register the correct order, and identify a suitable facility. The driver should bring valid government-issued photo identification and follow all instructions provided during scheduling.
Advance coordination is particularly important for post-accident, reasonable suspicion, alcohol, return-to-duty, and follow-up testing. These services may involve tighter timing, fewer qualified locations, or special collection procedures. Drivers should not independently choose the testing reason when the employer or designated employer representative is responsible for making that determination.
A compliant DOT program requires continuing oversight. Minnesota employers should treat drug and alcohol testing as an ongoing safety, administration, and recordkeeping responsibility rather than a single laboratory transaction.
Working with a consortium, collection facility, laboratory, medical review officer, or other service agent does not transfer the employer’s underlying regulatory responsibilities. Employers must continue monitoring the program, maintaining records, updating the covered-driver roster, and taking required action when a testing issue occurs.
Minnesota CDL drivers and employers should use current federal regulations and official FMCSA guidance when determining their responsibilities. FMCSA regulations establish controlled-substances and alcohol testing requirements for covered commercial drivers and employers. DOT procedural regulations govern how regulated tests are conducted and how employers, collectors, laboratories, medical review officers, and other program participants handle the testing process.
A complete compliance program involves more than sending a driver to a laboratory. Employers must identify covered drivers, maintain an appropriate testing program, administer random selections, provide required supervisor training, manage results, remove prohibited drivers from safety-sensitive functions, follow return-to-duty requirements, and preserve the required records.
Regulations and official agency guidance can be updated. Employers should review the current versions of the applicable requirements and obtain qualified professional guidance when a situation requires a formal legal or regulatory interpretation. CDL Inquiry provides testing coordination and consortium support but does not replace the employer’s legal counsel or regulatory decision-maker.
CDL Inquiry provides practical scheduling and consortium support that helps drivers and employers move from identifying a testing need to completing a properly registered collection.
We begin by identifying the testing reason requested by the employer. The employer remains responsible for required regulatory determinations, but accurate intake information helps prevent the wrong service from being ordered.
We search for an appropriate collection site near the driver’s Minnesota location or route. Site selection should consider the requested service because not every facility provides every type of DOT drug or alcohol collection.
The testing order should identify the correct DOT program and testing reason. Accurate registration helps the collection facility process the driver under the intended FMCSA testing requirement.
The driver receives the testing location and basic information needed to complete the collection. Drivers should arrive within the instructed period, present valid identification, and remain at the facility until the collection process is complete.
For enrolled drivers, CDL Inquiry manages random selection participation and scheduling support throughout the enrollment year. Employers must maintain accurate rosters and respond promptly when a driver is selected.
Confirming the facility, testing reason, and registration before the driver travels helps reduce unavailable services, rejected orders, duplicate trips, and confusion at the collection center.
Many testing problems begin with an administrative error rather than a deliberate compliance failure. A consistent process can help Minnesota employers avoid common scheduling, roster, documentation, and testing mistakes.
CDL Inquiry’s DOT consortium enrollment costs $110 per driver per year. The annual price includes the required pre-employment drug test and all random drug and random alcohol testing during the enrollment year.
Yes. The required pre-employment drug test is included with the $110 annual consortium enrollment. The employer must still wait for the appropriate verified result before permitting the driver to perform covered safety-sensitive work.
Yes. Drug and alcohol tests resulting from the consortium’s random selection process are included during the enrollment year. The employer and selected driver must follow the instructions and complete the required test promptly.
Yes. Covered Minnesota owner-operators can enroll for independently administered random testing participation. Owner-operators must keep their contact information current, remain available for selections, and follow testing instructions when selected.
CDL Inquiry can help locate an appropriate collection facility based on the driver’s location and the required testing service. Site availability and collection hours vary, so the test should be registered before the driver travels.
CDL Inquiry can assist with collection-site coordination in communities throughout Minnesota. The available location will depend on the testing reason, required service, operating hours, and the driver’s current location.
Appointment policies vary by facility. Some locations accept properly registered walk-ins, while others require appointments or maintain limited collection hours. Contact CDL Inquiry before sending the driver to the facility.
The driver should bring valid government-issued photo identification and any scheduling or registration information provided by CDL Inquiry. The driver should arrive within the instructed period and follow the collector’s directions.
CDL Inquiry charges $65 for the post-accident drug test and $65 for the post-accident alcohol test. The employer must first determine whether the accident meets the applicable FMCSA post-accident testing criteria.
No. Not every accident automatically triggers FMCSA post-accident testing. The employer must compare the facts with the applicable federal criteria and document the decision.
Return-to-duty and follow-up direct-observation tests cost $95 per test through CDL Inquiry. They must be scheduled under the appropriate testing reason and completed as part of the applicable process.
No. A standard or incorrectly registered test should not be used as a substitute for a required return-to-duty test. The driver must complete the applicable process, and the test must be ordered and collected correctly.
The driver should not visit a facility without first confirming the registration and site capability. An urgent-care center may not provide the required DOT service, alcohol test, or direct-observation collection.
No. A consortium can provide valuable administration and scheduling support, but the employer remains responsible for maintaining its program, responding to selections, updating the driver roster, preserving records, and taking required action.
Get help coordinating the correct DOT drug or alcohol test in Minnesota, or enroll a covered driver in our $110 annual consortium program with the pre-employment drug test and all random drug and alcohol testing included.
CDL Inquiry provides testing coordination and consortium support. Employers remain responsible for determining regulatory coverage, maintaining required records, and complying with applicable FMCSA and DOT requirements.